ProCE Banner Activity

Novel Combinatorial Approaches With TROP-2–Targeted Therapy in Advanced NSCLC

Slideset

Download this slideset with data on treatment approaches combining TROP-2–targeted ADCs with chemotherapy and immunotherapy.

Released: July 10, 2024

Expiration: July 09, 2025

Share

Faculty

Matthew Gubens

Matthew Gubens, MD, MS, FASCO

Professor of Medicine
Medical Director, Thoracic Medical Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.